Markets:

Overview

News

Currencies

International

Treasuries

Virios Therapeutics, Inc. - Common Stock (NQ:VIRI)

0.1550 UNCHANGED

Last Price Updated: 4:00 PM EDT, Oct 8, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Virios Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Dow, S&P 500 Drop In Volatile Trading Ahead Of Fed's Rate Decision ↗

September 19, 2022

U.S. stocks traded lower in volatile trading toward the end of trading, with the Dow Jones dropping around 40 points on Monday.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

September 19, 2022

Via Benzinga

Analyzing Virios Therapeutics's Short Interest ↗

September 19, 2022

Virios Therapeutics's (NASDAQ:VIRI) short percent of float has risen 6.58% since its last report. The company recently reported that it has 53 thousand shares sold short, which is...

Via Benzinga

Why Is Virios Therapeutics (VIRI) Stock Down 71% Today? ↗

September 19, 2022

Virios Therapeutics (VIRI) stock is falling hard on Monday after revealing results from its Phase 2b Study of IMC-1 in Fibromyalgia.

Via InvestorPlace

US Stocks Open Lower; Housing Market Index Drops In September ↗

September 19, 2022

U.S. stocks traded lower this morning, after recording losses in the previous week.

Via Benzinga

Virios Therapeutics Shares Tank After Failing Fibromyalgia Study ↗

September 19, 2022

Via Benzinga

Earnings Scheduled For August 11, 2022 ↗

August 11, 2022

Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million.

Via Benzinga

Virios Therapeutics: Q1 Earnings Insights ↗

May 12, 2022

Virios Therapeutics (NASDAQ:VIRI) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Earnings Scheduled For November 11, 2021 ↗

November 11, 2021

Companies Reporting Before The Bell • NICE (NASDAQ:NICE) is likely to report quarterly earnings at $1.58 per share on revenue of $465.75 million. • Reshape...

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

September 19, 2022

On Monday, 429 stocks made new 52-week lows.

Via Benzinga

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight ↗

August 08, 2021

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...

Via Benzinga

Why Virios Therapeutics Is Trading Lower By Over 71%, Here Are 55 Stocks Moving In Monday's Mid-Day Session ↗

September 19, 2022

Gainers MicroCloud Hologram Inc. (NASDAQ: HOLO) shares jumped 134.6% to $19.74.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

September 19, 2022

Via Benzinga

Recap Of Monday's Biotech Catalysts - End Of the Day Summary ↗

August 15, 2022

Via Benzinga

This Technology Stock Jumped 55% Following Q2 Results; Here Are 96 Biggest Movers From Yesterday ↗

August 17, 2022

Gainers Eargo, Inc. (NASDAQ: EAR) jumped 77.2% to close at $2.02. The FDA finalized rule enabling access to over-the-counter hearing aids.

Via Benzinga

Virios Therapeutics Commences Mid-Stage Long-COVID Study ↗

August 15, 2022

Virios Therapeutics (Nasdaq: VIRI) has initiated patient dosing in its exploratory Long-COVID trial evaluating IMC-2 (valacyclovir + celecoxib).

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

July 15, 2022

Via Benzinga

Preview: Virios Therapeutics's Earnings ↗

May 11, 2022

Virios Therapeutics (NASDAQ:VIRI) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Virios...

Via Benzinga

Virios Therapeutics: Q4 Earnings Insights ↗

March 17, 2022

Virios Therapeutics (NASDAQ:VIRI) reported its Q4 earnings results on Thursday, March 17, 2022 at 07:00 AM. Here's what investors need to know about the announcement....

Via Benzinga

A Preview Of Virios Therapeutics's Earnings ↗

March 16, 2022

Virios Therapeutics (NASDAQ:VIRI) is set to give its latest quarterly earnings report on Thursday, 2022-03-17. Here's what investors need to know before the announcement. Analysts...

Via Benzinga

An Innovative Approach To Antiviral Therapies And Treating Fibromyalgia (FM) Disease? ↗

February 02, 2022

Photo by Fusion Medical Animation on Unsplash Greg Duncan, Chairman and CEO of Virios Therapeutics Inc. (NASDAQ: VIRI), was a guest speaker at Benzinga’s All Access on Jan. 28, 2022.

Via Benzinga

Earnings Scheduled For May 12, 2022 ↗

May 12, 2022

Companies Reporting Before The Bell • Chicago Atlantic Real (NASDAQ:REFI) is projected to report earnings for its first quarter.

Via Benzinga

Earnings Scheduled For March 17, 2022 ↗

March 17, 2022

Companies Reporting Before The Bell • TransGlobe Energy (NASDAQ:TGA) is estimated to report earnings for its fourth quarter. • Ikena Oncology (NASDAQ:IKNA) is...

Via Benzinga

Benzinga Announces This Week's All Access Guests ↗

January 27, 2022

Benzinga is thrilled to announce the guest lineup for our next All Access show, presented by RedChip, set to air Friday, January 28 at 9:15 am ET. The Lineup 9:15 am:...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2021 ↗

December 15, 2021

Upgrades B of A Securities upgraded the previous rating for ONE Gas Inc (NYSE:

Via Benzinga

64 Biggest Movers From Yesterday ↗

November 02, 2021

Gainers ABVC BioPharma, Inc. (NASDAQ: ABVC) shares climbed 137.4% to close at $6.03 on Monday on abnormally-high volume. The stock is seeing increased interest by traders on...

Via Benzinga

Fibromyalgia Treatment: 3 Pillars that Set Virios Therapeutics Apart from the Rest ↗

July 08, 2021

The success of any company most often begins with a solid foundation and strong pillars. These two are essential ingredients to the growth of a company. Weak foundations or...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

August 20, 2021

On Friday morning, 155 companies achieved new lows for the year. Interesting Points: Marqeta (NASDAQ:MQ) was the largest firm on a market cap basis to set a new 52-...

Via Benzinga

The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma ↗

August 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (...

Via Benzinga

Earnings Scheduled For August 12, 2021 ↗

August 12, 2021

Companies Reporting Before The Bell • Anavex Life Sciences (NASDAQ:AVXL) is estimated to report earnings for its third quarter. • ITeos Therapeutics (NASDAQ:ITOS...

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Virios Therapeutics, Inc. - Common Stock (NQ:VIRI)

Headline News about Virios Therapeutics, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today